Zyversa Therapeutics
ZVSA • NASDAQ
Zyversa Therapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Stephen C. Glover.
CEOStephen C. Glover
Next Earnings
No upcoming earnings scheduled for Zyversa Therapeutics
No earnings announcement scheduled
Earnings History
Past 11 earnings reports for Zyversa Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 19, 2025 | Q3 2025 | -$2.56 | — | - | — |  10-Q |
| Aug 13, 2025 | Q2 2025 | -$0.46 | — | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.73 | — | - | — | 10-Q |
| Nov 14, 2024 | Q3 2024 | -$2.43Est: -$3.70 | +34.3% | - | — | 10-Q |
| Aug 9, 2024 | Q2 2024 | -$3.31Est: -$3.75 | +11.7% | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$4.53Est: -$3.70 | -22.4% | - | — | 10-Q |
| Mar 25, 2024 | Q4 2023 | -$0.25Est: -$42.80 | +99.4% | - | — | 10-K/A |
| Nov 14, 2023 | Q3 2023 | -$63.00Est: -$112.00 | +43.8% | - | — | — |
| Aug 21, 2023 | Q2 2023 | -$3,388.00 | — | - | — | 10-Q |
| May 12, 2023 | Q1 2023 | -$273.00 | — | - | — | — |
| Apr 3, 2023 | Q4 2022 | -$7.00 | — | - | — | — |